The Mechanisms of Acquired Resistance to Anti-Egfr Drugs in Non-Small Cell Lung Cancer Not Associated With T790m Mutation and Their Significance in Clinical Practice
Advances in molecular oncology
doi 10.17650/2313-805x-2018-5-3-17-24
Full Text
Open PDFAbstract
Available in full text
Date
November 10, 2018
Authors
Publisher
Publishing House ABV Press